ex vivo-activated autologous lymph node lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-013479
Autologous human lymph node T-lymphocytes, with potential immunostimulatory and antineoplastic activity. Upon collection of immune cells from the tumor-draining lymph node, the human lymph node lymphocytes are activated with anti-CD3/anti-CD28 microbeads, cultured with recombinant, human interleukin-2 (IL-2), expanded and isolated ex vivo. Upon reintroduction into the patient, the ex vivo-activated autologous lymph node lymphocytes recognize and lyse the tumor cells.
| Identifier | MLC-T-ONC-013479 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | X-ACT autologous lymph node lymphocytes; X-ACT |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013479",
"term": "ex vivo-activated autologous lymph node lymphocytes",
"field": "Oncology and biomedicine",
"definition": "Autologous human lymph node T-lymphocytes, with potential immunostimulatory and antineoplastic activity. Upon collection of immune cells from the tumor-draining lymph node, the human lymph node lymphocytes are activated with anti-CD3/anti-CD28 microbeads, cultured with recombinant, human interleukin-2 (IL-2), expanded and isolated ex vivo. Upon reintroduction into the patient, the ex vivo-activated autologous lymph node lymphocytes recognize and lyse the tumor cells.",
"synonyms": [
"X-ACT autologous lymph node lymphocytes",
"X-ACT"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ex-vivo-activated-autologous-lymph-node-lymphocytes/"
}
Record 7,014 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.